Elevance Health stock gains 3.20% to EUR 395.25 premarket
Published on 11/16/2026 at 08:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Matters Before Trading
- Elevance Health provides medical, digital, pharmaceutical, behavioral-health and clinical care solutions.
- The company serves consumers, families and communities through its health benefits business.
Elevance Health stock traded at EUR 395.25 on Lang & Schwarz at 08:06 CET on Monday, November 16, 2026, 3.20 percent above the Xetra close of Friday, November 13, 2026.
Elevance Health operates a broad health benefits business serving consumers, families and communities. Its offering spans medical, digital, pharmaceutical, behavioral-health and clinical solutions, giving investors exposure to several parts of the healthcare-services market.
The broader US market is tracked by the S&P 500.
Disclaimer...
en | US0367521038 | ELEVANCE HEALTH | boerse | 70519642 | bgmi
